Lowest Price Guaranteed
Pages
224
Last Updated
April 2026
View Count
21189
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Exoskeleton
5.3. History of Exoskeleton
5.4. Classification of Exoskeleton
5.4.1. Based on Body Part Supported
5.4.2. Based on Form of Exoskeleton
5.4.3. Based on Mode of Operation
5.4.4 Based on Mobility
5.5. Applications of Exoskeleton
5.6. Features of Exoskeleton
5.7. Limitations of Exoskeleton
5.8. Future Perspectives
6. MEDICAL EXOSKELETON: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Exoskeleton: Overall Market Landscape
6.2.1. Analysis by Status of Development
6.2.2. Analysis by Type of Body Part Covered
6.2.3. Analysis by Mode of Operation
6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
6.2.5. Analysis by Form of Exoskeleton
6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
6.2.8. Analysis by Device Mobility
6.2.9. Analysis by Mode of Operation and Device Mobility
6.2.10. Analysis by Form of Exoskeleton and Device Mobility
6.2.11. Analysis by Type of Body Part Covered and Device Mobility
6.2.12. Analysis by User-Machine Interface
6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
6.2.14. Analysis by Mode of Operation and User-Machine Interface
6.2.15. Analysis by Availability of Advanced Features
6.2.16. Analysis by End User
6.2.17. Analysis by Patient Age Group
6.2.18. Analysis by Exoskeleton Setting for Patients
6.2.19. Analysis by Breakthrough Designation
6.3. Medical Exoskeleton: Developer: Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters
6.3.5. Analysis by Company Ownership
6.3.6. Analysis by Location of Headquarters and Company Ownership
6.3.7. Analysis by Additional Services Offered
6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton
7. MEDICAL EXOSKELETON: PRODUCT COMPETITVENESS ANALYSIS
7.1 Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Medical Exoskeleton: Product Competitiveness Analysis
7.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
7.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
7.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
7.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
7.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
7.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
7.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
7.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
7.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton
8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. CYBERDYNE
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Product Portfolio
8.2.4 Recent Developments and Future Outlook
8.3. Ekso Bionics
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Product Portfolio
8.3.4 Recent Developments and Future Outlook
8.4. ExoAtlet
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Fourier Intelligence
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Gloreha
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Recent Developments and Future Outlook
8.7. Guangzhou Yikang
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Recent Developments and Future Outlook
8.8. Hexar Humancare
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Recent Developments and Future Outlook
8.9. Hocoma
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Recent Developments and Future Outlook
8.10. Panasonic
8.10.1. Company Overview
8.10.2. Financial Information
8.10.3. Product Portfolio
8.10.4. Recent Developments and Future Outlook
8.11. Tyromotion
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Recent Developments and Future Outlook
9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Bionic Yantra
9.3. MediTouch
9.4. Milebot Robotics
9.5. Myomo
9.6. Neofect
9.7. NextStep Robotics
9.8. ReWalk Robotics
9.9. Rex Bionics
9.10. Roam Robotics
9.11. Trexo Robotics
9.12. U&O Technologies
10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Medical Exoskeleton: List of Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Type of Partner
10.3.5. Analysis by Year of Partnership and Type of Partner
10.3.6. Analysis by Purpose of Partnership
10.3.7. Analysis by Geography
10.3.7.1. Local and International Agreements
10.3.7.2. Intracontinental and Intercontinental Agreements
10.3.7.3. Most Active Players: Distribution by Number of Partnerships
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Exoskeleton: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Leading Players: Analysis by Number of Patents
11.3.9. Leading Patent Assignees: Analysis by Number of Patents
11.4. Exoskeleton: Patent Benchmarking
11.4.1. Analysis by Patent Characteristics
11.4.2. Exoskeleton: Patent Valuation
11.5. Leading Players by Number of Citations
12. BLUE OCEAN STRATEGY
12.1. Overview of Blue Ocean Strategy
12.1.1. Red Oceans
12.1.2. Blue Oceans
12.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
12.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
12.1.4.1. Strategy Canvas
12.1.4.2. Pioneer-Migrator-Settler (PMS) Map
12.1.4.3. Buyer Utility Map
13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
13.1. Chapter Overview
13.2. Market Drivers
13.3. Market Restraints
13.4. Market Opportunities
13.5. Market Challenges
13.6. Conclusion
14. MEDICAL EXOSKELETON MARKET
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.1. Scenario Analysis
14.4. Key Market Segmentations
14.5. Dynamic Dashboard
15. EXOSKELETON MARKET, BY BODY PART COVERED
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.6. Data Triangulation and Validation
16. EXOSKELETON MARKET, BY MODE OF OPERATION
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation and Validation
17. EXOSKELETON MARKET, BY THEIR FORM
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Data Triangulation and Validation
18. EXOSKELETON MARKET, BY THEIR MOBILITY
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation and Validation
19. EXOSKELETON MARKET, BY END USERS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation and Validation
20. EXOSKELETON MARKET, BY GEOGRAPHY
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7. Data Triangulation and Validation
21. CONCLUSION
22. EXECUTIVE INSIGHTS
22.1. Chapter Overview
22.2. Spain-based Small Company
22.2.1. Company Snapshot
22.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
22.3. Japan-based Small Company
22.3.1. Company Snapshot
22.3.2. Interview Transcript: Director of Business Planning and Development
22.4. US-based Small Company
22.4.1. Company Snapshot
22.4.2. Interview Transcript: Vice President of Sales and Marketing
22.5. Canada-based Small Company
22.5.1. Company Snapshot
22.5.2. Interview Transcript: Marketing and Design Manager
22.6. India-based Small Company
22.6.1. Company Snapshot
22.6.2. Interview Transcript: Founder and Director
23. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS
24. APPENDIX 2: TABULATED DATA
25. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION
Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Medical Exoskeleton Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Patent Analysis
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Types of Mobility Assistive Devices
Figure 5.2 Key Historical Events related to Exoskeleton
Figure 5.3 Classification of Exoskeleton
Figure 5.4 Applications of Exoskeleton
Figure 5.5 Movements Supported by Lower Body, Upper Body and Full Body Exoskeleton
Figure 5.6 Components of a Powered / Robotic Exoskeleton
Figure 5.7 Features of Exoskeleton
Figure 5.8 Limitations of Exoskeleton
Figure 6.1 Medical Exoskeleton: Distribution by Status of Development
Figure 6.2 Medical Exoskeleton: Distribution by Type of Body Part Covered
Figure 6.3 Medical Exoskeleton: Distribution by Mode of Operation
Figure 6.4 Medical Exoskeleton: Distribution Type of Body Part Covered and Mode of Operation
Figure 6.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Figure 6.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Figure 6.7 Medical Exoskeleton: Distribution Type of Body Part Covered and Form of Exoskeleton
Figure 6.8 Medical Exoskeleton: Distribution by Device Mobility
Figure 6.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Figure 6.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Figure 6.11 Medical Exoskeleton: Distribution by Type of Body Part Covered and Device Mobility
Figure 6.12 Medical Exoskeleton: Distribution by User-Machine Interface
Figure 6.13 Medical Exoskeleton: Distribution by Type of Body Part Covered and User-Machine Interface
Figure 6.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Figure 6.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Figure 6.16 Medical Exoskeleton: Distribution by End User
Figure 6.17 Medical Exoskeleton: Distribution by Patient Age Group
Figure 6.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Figure 6.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Figure 6.20 Medical Exoskeleton Companies: Distribution by Year of Establishment
Figure 6.21 Medical Exoskeleton Companies : Distribution by Company Size
Figure 6.22 Medical Exoskeleton Companies : Distribution by Company Size and Employee Count
Figure 6.23 Medical Exoskeleton Companies : Distribution by Location of Headquarters (Region)
Figure 6.24 Medical Exoskeleton Companies : Distribution by Location of Headquarters (Country)
Figure 6.25 Medical Exoskeleton Companies : Distribution by Company Size and Location of Headquarters
Figure 6.26 Medical Exoskeleton Companies : Distribution by Company Ownership
Figure 6.27 Medical Exoskeleton Companies : Distribution by Location of Headquarters and Company Ownership
Figure 6.28 Medical Exoskeleton Companies : Distribution by Additional Services Offered
Figure 6.29 Most Active Players: Distribution by Number of Medical Exoskeleton Location of Headquarters (Country)
Figure 7.1 Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
Figure 7.2 Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
Figure 7.3 Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
Figure 7.4 Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
Figure 7.5 Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
Figure 7.6 Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
Figure 7.7 Product Competitiveness Analysis: Full Body Medical Exoskeleton
Figure 8.1 CYBERDYNE: Annual Revenues, FY 2019 – FY 2023 (JPY Billion)
Figure 8.2 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Figure 8.3 Ekso Bionics: Annual Revenues, 2018 – Q1 2023 (USD Billion)
Figure 8.4 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Figure 8.5 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 10.6 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 10.7 Partnerships and Collaborations: Local and International Agreements
Figure 10.8 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 10.9 Most Active Players: Distribution by Number of Partnerships
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Figure 11.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Figure 11.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Figure 11.5 Patent Analysis: Distribution by Publication Time
Figure 11.6 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Figure 11.7 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Figure 11.8 Patent Analysis: Distribution by CPC Symbols
Figure 11.9 Patent Analysis: Distribution by Type of Applicant
Figure 11.10 Leading Industry Players: Distribution by Number of Patents
Figure 11.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.12 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.13 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 11.14 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 11.15 Patent Analysis: Distribution by Patent Age
Figure 11.16 Patent Analysis: Patent Valuation
Figure 12.1 Differences Between Red Ocean Strategy and Blue Ocean Strategy
Figure 12.2 Blue Ocean Strategy: Strategy Canvas
Figure 12.3 Blue Ocean Strategy: Pioneer- Migrator-Settler (PMS) Map
Figure 12.4 Blue Ocean Strategy: Buyer Utility Map
Figure 13.1 Market Drivers
Figure 13.2 Market Restrains
Figure 13.3 Market Opportunities
Figure 13.4 Market Challenges
Figure 14.1 Medical Exoskeleton Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
Figure 14.2 Medical Exoskeleton Market, Future Estimates (2023-2035), Base Scenario (USD Million)
Figure 14.3 Medical Exoskeleton Market, Future Estimates (2023-2035), Conservative Scenario (USD Million)
Figure 14.4 Medical Exoskeleton Market, Future Estimates (2023-2035), Optimistic Scenario (USD Million)
Figure 15.1 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Figure 15.2 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 15.3 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 15.4 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.1 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Figure 16.2 Medical Powered Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.3 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.4 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.1 Medical Exoskeleton Market: Distribution by Form, 2018, 2023 and 2035 (USD Million)
Figure 17.2 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.3 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.1 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Figure 18.2 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.3 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 19.1 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
Figure 19.2 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 19.3 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.1 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
Figure 20.2 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.3 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.4 Medical Exoskeleton Market in Asia- Pacific: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.5 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.4 Concluding Remarks: Overall Medical Exoskeleton Market Landscape
Figure 21.3 Concluding Remarks: Partnerships and Collaborations
Figure 21.4 Concluding Remarks: Patent Analysis
Figure 21.5 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 5.1 Contrasting Characteristics: Medical and Non-Medical Exoskeleton
Table 5.2 Degrees of Freedom in Each Joint of Lower Exoskeleton
Table 5.3 Contrasting Characteristics: Rigid and Soft Exoskeleton
Table 6.1 Medical Exoskeleton: Information on Status of Development, Type of Body Part Covered and Mode of Operation
Table 6.2 Medical Exoskeleton: Information on Form of Exoskeleton, Device Mobility and User-Machine Interface
Table 6.3 Medical Exoskeleton: Information on Advanced Features and End Users
Table 6.4 Medical Exoskeleton: Information on Patient Age Group, Exoskeleton Setting for Patients and Breakthrough Designation
Table 6.5 Medical Exoskeleton: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
Table 6.6 Medical Exoskeleton: List of Developers
Table 6.7 Medical Exoskeleton: Information on Additional Services Offered
Table 8.1 List of Medical Exoskeleton Companies Profiled
Table 8.2 CYBERDYNE: Company Snapshot
Table 8.3 CYBERDYNE: Medical Exoskeleton Portfolio
Table 8.4 CYBERDYNE: Recent Developments and Future Outlook
Table 8.5 Ekso Bionics: Company Snapshot
Table 8.6 Ekso Bionics: Medical Exoskeleton Portfolio
Table 8.7 Ekso Bionics: Recent Developments and Future Outlook
Table 8.8 ExoAtlet: Company Snapshot
Table 8.9 ExoAtlet: Medical Exoskeleton Portfolio
Table 8.10 ExoAtlet: Recent Developments and Future Outlook
Table 8.11 Fourier Intelligence: Company Snapshot
Table 8.12 Fourier Intelligence: Medical Exoskeleton Portfolio
Table 8.13 Fourier Intelligence: Recent Developments and Future Outlook
Table 8.14 Gloreha: Company Snapshot
Table 8.15 Gloreha: Medical Exoskeleton Portfolio
Table 8.16 Gloreha: Recent Developments and Future Outlook
Table 8.17 Guangzhou YiKang: Company Snapshot
Table 8.18 Guangzhou YiKang: Medical Exoskeleton Portfolio
Table 8.19 Guangzhou YiKang: Recent Developments and Future Outlook
Table 8.20 Hexar Humancare: Company Snapshot
Table 8.21 Hexar Humancare: Medical Exoskeleton Portfolio
Table 8.22 Hexar Humancare: Recent Developments and Future Outlook
Table 8.23 Hocoma: Company Snapshot
Table 8.24 Hocoma: Medical Exoskeleton Portfolio
Table 8.25 Hocoma: Recent Developments and Future Outlook
Table 8.26 Panasonic: Company Snapshot
Table 8.27 Panasonic: Medical Exoskeleton Portfolio
Table 8.28 Panasonic: Recent Developments and Future Outlook
Table 8.29 Tyromotion: Company Snapshot
Table 8.30 Tyromotion: Medical Exoskeleton Portfolio
Table 8.31 Tyromotion: Recent Developments and Future Outlook
Table 9.1 Bionic Yantra: Company Snapshot and Product Portfolio
Table 9.2 Bionic Yantra: Medical Exoskeleton Portfolio
Table 9.3 MediTouch: Company Snapshot
Table 9.4 MediTouch: Medical Exoskeleton Portfolio
Table 9.5 Milebot Robotics: Company Snapshot
Table 9.6 Milebot Robotics: Medical Exoskeleton Portfolio
Table 9.7 Milebot Robotics: Non- Medical Exoskeleton Portfolio
Table 9.8 Myomo: Company Snapshot
Table 9.9 Myomo: Medical Exoskeleton Portfolio
Table 9.10 Neofect: Company Snapshot
Table 9.11 Neofect: Medical Exoskeleton Portfolio
Table 9.12 NextStep Robotics: Company Snapshot
Table 9.13 NextStep Robotics: Medical Exoskeleton Portfolio
Table 9.14 ReWalk Robotics: Company Snapshot
Table 9.15 ReWalk Robotics: Medical Exoskeleton Portfolio
Table 9.16 REX Bionics: Company Snapshot
Table 9.17 REX Bionics: Medical Exoskeleton Portfolio
Table 9.18 Roam Robotics: Company Snapshot
Table 9.19 Roam Robotics: Medical Exoskeleton Portfolio
Table 9.20 Trexo Robotics: Company Snapshot
Table 9.21 Trexo Robotics: Medical Exoskeleton Portfolio
Table 9.22 U&O Technologies: Company Snapshot
Table 9.23 U&O Technologies: Medical Exoskeleton Portfolio
Table 10.1 Medical Exoskeleton: List of Partnerships and Collaborations
Table 11.1 Patent Analysis: Top CPC Sections
Table 11.2 Patent Analysis: Top CPC Symbols
Table 11.3 Patent Analysis: List of Top CPC Codes
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 24.1 Medical Exoskeleton: Distribution by Status of Development
Table 24.2 Medical Exoskeleton: Distribution by Body Part Covered
Table 24.3 Medical Exoskeleton: Distribution by Mode of Operation
Table 24.4 Medical Exoskeleton: Distribution by Body Part Covered and Mode of Operation
Table 24.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Table 24.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Table 24.7 Medical Exoskeleton: Distribution by Body Part Covered and Form of Exoskeleton
Table 24.8 Medical Exoskeleton: Distribution by Device Mobility
Table 24.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Table 24.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Table 24.11 Medical Exoskeleton: Distribution by Body Part Covered and Device Mobility
Table 24.12 Medical Exoskeleton: Distribution by User-Machine Interface
Table 24.13 Medical Exoskeleton: Distribution by Body Part Covered and User-Machine Interface
Table 24.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Table 24.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Table 24.16 Medical Exoskeleton: Distribution by End User
Table 24.17 Medical Exoskeleton: Distribution by Patient Age Group
Table 24.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Table 24.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Table 24.20 Medical Exoskeleton Developers: Distribution by Year of Establishment
Table 24.21 Medical Exoskeleton Developers: Distribution by Company Size
Table 24.22 Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Table 24.23 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Table 24.24 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Table 24.25 Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Table 24.26 Medical Exoskeleton Developers: Distribution by Company Ownership
Table 24.27 Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Table 24.28 Medical Exoskeleton Developers: Distribution by Additional Services Offered
Table 24.29 Most Active Players: Distribution by Number of Medical Exoskeleton
Table 24.30 CYBERDYNE: Annual Revenues, FY2019 – FY2023 (JPY Billion)
Table 24.31 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Table 24.32 Ekso Bionics: Annual Revenues, 2018 – Q1 2023 (USD Billion)
Table 24.33 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Table 24.34 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Table 24.35 Partnerships and Collaborations: Distribution by Year of Partnership
Table 24.36 Partnerships and Collaborations: Distribution by Type of Partnership
Table 24.37 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 24.38 Partnerships and Collaborations: Distribution by Type of Partner
Table 24.39 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 24.40 Partnerships and Collaborations: Distribution by Purpose of Partnership
Table 24.41 Partnerships and Collaborations: Local and International Agreements
Table 24.42 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 24.43 Most Active Players: Distribution by Number of Partnerships
Table 24.44 Patent Analysis: Distribution by Type of Patent
Table 24.45 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016- 2022
Table 24.46 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Table 24.47 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Table 24.48 Patent Analysis: Distribution by Publication Time
Table 24.49 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Table 24.50 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Table 24.51 Patent Analysis: Distribution by CPC Symbols
Table 24.52 Patent Analysis: Distribution by Type of Applicant
Table 24.53 Leading Industry Players: Distribution by Number of Patents
Table 24.54 Leading Non-Industry Players: Distribution by Number of Patents
Table 24.55 Leading Individual Assignees: Distribution by Number of Patents
Table 24.56 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 24.57 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 24.58 Patent Analysis: Distribution by Patent Age
Table 24.59 Patent Analysis: Patent Valuation
Table 24.60 Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 24.61 Medical Exoskeleton Market, Forecasted Estimates (2023-2035), Base Scenario (USD Million)
Table 24.62 Medical Exoskeleton Market, Forecasted Estimates (2023-2035) Conservative Scenario (USD Million)
Table 24.63 Medical Exoskeleton Market, Forecasted Estimates (2023-2035), Optimistic Scenario (USD Million)
Table 24.64 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Table 24.65 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.66 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.67 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.68 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Table 24.69 Medical Powered Exoskeleton Market: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 24.70 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.71 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.72 Medical Exoskeleton Market: Distribution by Form 2018, 2023 and 2035 (USD Million)
Table 24.73 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.74 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.75 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Table 24.76 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.77 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.78 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
Table 24.79 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.80 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.81 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
Table 24.82 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 24.83 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 24.84 Medical Exoskeleton Market in Asia-Pacific: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 24.85 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Please contact our team for the details on the companies covered.